News

Novo Holdings participates in Hemab Therapeutics $135M Series B Financing

Hemab Therapeutics is a clinical-stage biotechnology company…

Methinks receives CE Marked Certification for AI-based stroke triage software

Methinks Stroke Suite is a disruptive technology that has the…

Zephyrus Innovations announces US FDA approval for its Aeroject™ 3ml safety syringe

Aeroject™ 3ml safety syringe is a single-use, affordable,…

Leucid Bio provides business update and outlook for 2023

Proprietary Lateral CAR Platform achieved pre-clinical…

Futura Medical to present MED3000 FM71 data at the European Society for Sexual Medicine Congress 2023

Futura Medical plc (AIM: FUM), a pharmaceutical company developing…

Novo Holdings Venture Investments team Newsletter

The Novo Holdings Venture Investments team has published its…

Sequana Medical announces 2022 Full Year Results and 2023 Outlook

alfapump® – successful primary endpoint read-out of North…

Sequana Medical announces grant of additional DSR® patent in United States

Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext…

Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer

Dr. Gericke brings extensive experience in the research and…

We’d love to hear from you

For more information about Optimum Strategic Communications, please get in touch.

© Optimum Strategic Communications.